Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis
暂无分享,去创建一个
K. Mawatari | T. Kitamori | Shinichi Sato | Y. Kazoe | Y. Asano | T. Taniguchi | Y. Ichimura | A. Yoshizaki | H. Shimizu | Kouki Nakamura | M. Hirabayashi | T. Yamashita | R. Saigusa | T. Fukasawa | S. Ebata | S. Miura | S. Sato | K. Nakamura | Megumi Hirabayashi | Takashi Taniguchi